ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

L.A. County decides against Supporting New Cancer Hospital

February 4, 1977

New Subcommittee Chairman Named

June 10, 1977

Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted

July 19, 1991

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008